In people with acute myeloid leukemia (AML), changes in the gene profile of blood-forming stem cells, leading to a more youthful blood cell profile, could…
News
PANCREATIC CANCER
PRKAA1 protein seen among pancreatic cancer biomarkers: Study
A protein called PRKAA1 could be among potential pancreatic cancer biomarkers and a possible treatment target, a study found. Levels of the protein were…
Researchers have uncovered genetic changes that may explain why certain brain tumors, known as gliomas, that are associated with IDHÂ gene mutations start off as…
GYNECOLOGICAL CANCER
Vulvar cancer possibly tied to bacteria not known in such cancers
The first recorded case of vulvar cancer that occurred alongside an infection with the Fusobacterium necrophorum bacteria was described in a recent case report…
Researchers in Belgium have developed an atlas to mark changes in distinct types of immune cells during multiple myeloma’s  progression. Their work, in…
The U.S. Food and Drug Administration (FDA) has approved an oral liquid formulation of imatinib, now called Imkeldi, to treat specific forms of…
PANCREATIC CANCER
Somatostatin may be safe option for certain tumors during pregnancy
For about one-third of women with a neuroendocrine tumor — or an abnormal mass of tissue that forms from hormone-releasing cells, such as those in…
GYNECOLOGICAL CANCER
Vitamin D seen to prevent ovarian cancer’s onset in disease models
Vitamin D may help to prevent the development of ovarian cancers, according to new studies in mice and cell disease models. “These data strongly…
The U.S. Food and Drug Administration (FDA) will review GSK’s request to approve Blenrep (belantamab mafodotin) as part of a combination treatment for adults…
The U.S. Food and Drug Administration (FDA) has approved revumenib, now called Revuforj, as an oral therapy for children and adults, ages 1 year and…
Recent Posts
- New AI-based tool aims to help guide treatment for pancreatic cancer
- Sometimes, in caregiving, acts of love can feel like unkindness
- FDA grants AMXT 1501 orphan drug status for malignant gliomas
- New CAR-NKT cell therapy targets endometrial cancer on two fronts
- Add-on mezigdomide slows cancer progression in hard-to-treat myeloma
